blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3906302

EP3906302 - ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  26.11.2021
Database last updated on 16.07.2024
FormerRequest for examination was made
Status updated on  08.10.2021
FormerThe international publication has been made
Status updated on  11.06.2021
Formerunknown
Status updated on  11.09.2020
Most recent event   Tooltip24.11.2023New entry: Decision on request for further processing 
Applicant(s)For all designated states
Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
[2021/45]
Inventor(s)01 / LAWRENCE, Shawn
c/o Regeneron Pharmaceutical, Inc. 777 Old Saw
Mill River Road
Tarrytown, New York 10591 / US
02 / JOHNSON, Amy
c/o Regeneron Pharmaceutical, Inc. 777 Old Saw
Mill River Road
Tarrytown, New York 10591 / US
03 / CASEY, Meghan
c/o Regeneron Pharmaceutical, Inc. 777 Old Saw
Mill River Road
Tarrytown, New York 10591 / US
04 / MASTROGIACOMO, Jaimie
c/o Regeneron Pharmaceutical, Inc. 777 Old Saw
Mill River Road
Tarrytown, New York 10591 / US
05 / WANG, Shunhai
c/o Regeneron Pharmaceutical, Inc. 777 Old Saw
Mill River Road
Tarrytown, New York 10591 / US
06 / LI, Ning
c/o Regeneron Pharmaceutical, Inc. 777 Old Saw
Mill River Road
Tarrytown, New York 10591 / US
[N/P]
Former [2021/45]01 / LAWRENCE, Shawn
Tarrytown, New York 10591 / US
02 / JOHNSON, Amy
Tarrytown, New York 10591 / US
03 / CASEY, Meghan
Tarrytown, New York 10591 / US
04 / MASTROGIACOMO, Jaimie
Tarrytown, New York 10591 / US
05 / WANG, Shunhai
Tarrytown, New York 10591 / US
06 / LI, Ning
Tarrytown, New York 10591 / US
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2021/45]
Application number, filing date20765397.318.08.2020
[2021/45]
WO2020US46823
Priority number, dateUS201962944635P06.12.2019         Original published format: US 201962944635 P
US202063065012P13.08.2020         Original published format: US 202063065012 P
[2021/45]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021112924
Date:10.06.2021
Language:EN
[2021/23]
Type: A1 Application with search report 
No.:EP3906302
Date:10.11.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 10.06.2021 takes the place of the publication of the European patent application.
[2021/45]
Search report(s)International search report - published on:EP10.06.2021
ClassificationIPC:C12N5/00
[2021/45]
CPC:
A61K38/179 (EP,IL,KR); C07K14/71 (EP,CN,IL,KR,US); A61K38/1866 (IL,US);
A61P17/06 (EP,IL); A61P19/02 (EP,IL); A61P27/02 (EP,IL);
A61P35/00 (EP,IL); C07K1/06 (US); C07K1/113 (IL,US);
C07K1/16 (IL,US); C07K1/165 (IL); C07K1/18 (IL,KR,US);
C07K1/20 (IL); C07K1/22 (IL,US); C07K1/36 (IL,US);
C07K16/22 (CN,IL,US); C07K16/28 (CN,IL); C07K16/283 (IL,US);
C12N15/66 (IL,US); C12N15/85 (CN,IL); C12N5/0018 (EP,IL,KR,US);
C12N5/0031 (EP,IL,US); C12P21/02 (IL,US); C12P21/06 (EP,IL,KR,US);
C12Y304/21004 (EP,IL); G01N30/80 (IL,US); C07K2317/622 (CN,IL,US);
C07K2319/30 (EP,CN,IL,KR,US); C07K2319/33 (CN,IL,US); C12N2500/20 (IL);
C12N2500/32 (IL); C12N2510/02 (IL); C12N2529/10 (KR);
C12N2800/10 (IL,US); G01N2030/027 (IL,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/45]
TitleGerman:ANTI-VEGF-PFLANZENPROTEINZUSAMMENSETZUNGEN UND VERFAHREN ZUR HERSTELLUNG DAVON[2021/45]
English:ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME[2021/45]
French:COMPOSITIONS DE PROTÉINES ANTI-VEGF ET LEURS PROCÉDÉS DE PRODUCTION[2021/45]
Entry into regional phase06.08.2021National basic fee paid 
06.08.2021Designation fee(s) paid 
06.08.2021Examination fee paid 
Examination procedure06.08.2021Amendment by applicant (claims and/or description)
06.08.2021Examination requested  [2021/45]
06.08.2021Date on which the examining division has become responsible
29.11.2021Despatch of a communication from the examining division (Time limit: M04)
08.04.2022Reply to a communication from the examining division
24.05.2022Despatch of a communication from the examining division (Time limit: M04)
04.10.2022Reply to a communication from the examining division
03.02.2023Despatch of a communication from the examining division (Time limit: M06)
05.09.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
15.11.2023Reply to a communication from the examining division
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
15.11.2023Request for further processing filed
15.11.2023Full payment received (date of receipt of payment)
Request granted
23.11.2023Decision despatched
Fees paidRenewal fee
19.08.2022Renewal fee patent year 03
22.08.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[T]WO2014145098  (GENENTECH INC [US], et al);
by applicantUS4534972
 US5721121
 US5952199
 US6100071
 US6171825
 WO0192337
 US6383486
 WO2005000895
 US6897294
 US6936441
 US7070959
 WO2007077217
 US2007212770
 US7279159
 US7306799
 US2008009040
 US7374757
 US7374758
 US7531173
 US7608261
 US7771721
 US7807164
 US8092803
 US8110546
 US8404638
 US8481046
 US8710004
 US8802107
 US8921316
 US8956830
 US9217168
 US9340594
 US9416167
 US9487810
 US9511140
 US9580489
 US9636400
 US9663810
 US9914763
 US9926583
 US10144944
 US10400025
 US10406226
 US10576128
 US10646546
 US20100823838
 US19430015223
 WO2020US15659
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.